Conference abstract · 15 Jul 2013
Conference abstract
Computational Pathology: Machines are Coming
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
There is an urgent need for alternative methods to objectively diagnose and classify tumours and for identification of significant new tumour subtypes. Computational pathology offers an opportunity for consistent and automated evaluation and stratification of tumour phenotype. Although knowledge of the molecular basis of tumours is rapidly increasing, histomorphology based diagnostic subtyping and recognition of new subtypes remains dependent on the subjective and limited morphological diagnosis of expert pathologists. The limitations of this classical approach are demonstrated in the inter-observer reproducibility that generally shows acceptable-values only for typical tumour growth patterns and when expert opinion is obtained. Deep learning approaches in computational pathology have already shown excellent performance in a range of image classification challenges, and are set to revolutionize biomedical research, clinical practice, and the healthcare industry. Artificial Intelligence (AI) applications, for example using convolutional neural networks, can analyse and grade tumour tissue biopsies; a task currently performed by pathologists. Similarly, computational pathology and concurrent deep learning approaches are also creating novel tools to link mutational status and gene expression to phenotype. Deep learning in computational pathology has been shown to be able to identify prognostic factors and determine genotype-phenotype correlations in various types of cancer. Computational pathology and omics are part of an integrative approach that is set to accelerate our ability to interrogate biologically relevant pathways in cancer. This will require a multidisciplinary approach of pathology, computational science, mathematics, molecular biology and clinical data. Ultimately, computational pathology and it’s applications in AI will lead to improved options for individualized therapy and accelerate the future development of new treatment pathways.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 17 Mar 2023
Computational Pathology: Advancing Diagnosis through Machine Learning
Opinion · 15 Feb 2023
Computational and Machine Learning in Pathology
Commentary · 3 Feb 2023
Computational Intelligence and Machine Learning in Bioinformatics and Computational Biology
Mini review · 2018
Computational-Based Approaches in Epigenetic Research: Insights from Computational Tools, Mathematical Models, and Machine Learning Methods
More from this journal
The newest in Biochemistry & Molecular Biology Journal.
Article · 17 Aug 2026
The Role of Human Tumor Necrosis Factor-andalpha; (TNF-andalpha;) in Predicting Diabetic Nephropathy in Type ? Diabetic Patients
Article · 21 May 2026
Kinetic Perspectives on Enzyme-Catalyzed Reactions in Biological Systems
Article · 21 May 2026
Structural Pathways and Stability in Protein Folding
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiochemistry & Molecular Biology Journal
- SubjectBiochemistry & Biotechnology
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Jan Lukas Robertus”
